These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

315 related items for PubMed ID: 1647829

  • 1. Prevention of cytomegalovirus infection following bone marrow transplantation: a randomized trial of blood product screening.
    Miller WJ, McCullough J, Balfour HH, Haake RJ, Ramsay NK, Goldman A, Bowman R, Kersey J.
    Bone Marrow Transplant; 1991 Mar; 7(3):227-34. PubMed ID: 1647829
    [Abstract] [Full Text] [Related]

  • 2. Transfusion support using filtered unscreened blood products for cytomegalovirus-negative allogeneic marrow transplant recipients.
    Narvios AB, Przepiorka D, Tarrand J, Chan KW, Champlin R, Lichtiger B.
    Bone Marrow Transplant; 1998 Sep; 22(6):575-7. PubMed ID: 9758346
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Prophylactic use of ganciclovir for allogeneic bone marrow transplant recipients.
    von Bueltzingsloewen A, Bordigoni P, Witz F, Bene MC, Schmitt C, Lacour B, Sommelet D.
    Bone Marrow Transplant; 1993 Sep; 12(3):197-202. PubMed ID: 8241976
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Graft-versus-leukaemia activity associated with CMV-seropositive donor, post-transplant CMV infection, young donor age and chronic graft-versus-host disease in bone marrow allograft recipients. The Nordic Bone Marrow Transplantation Group.
    Jacobsen N, Badsberg JH, Lönnqvist B, Ringdén O, Volin L, Rajantie J, Nikoskelainen J, Keiding N.
    Bone Marrow Transplant; 1990 Jun; 5(6):413-8. PubMed ID: 2164434
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. CMV infections in bone marrow transplanted patients--evaluation of prophylaxis with Cytotect (CMV hyperimmuneglobulin).
    Zintl F, Färber I, Hermann J, Fuchs D, Prager J, Wutzler P.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1989 Jun; 116(3-4):557-64. PubMed ID: 2480308
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Risk factors for cytomegalovirus infection in BMT recipients transfused exclusively with seronegative blood products.
    Rubie H, Attal M, Campardou AM, Gayet-Mengelle C, Payen C, Sanguignol F, Calot JP, Charlet JP, Robert A, Huguet F.
    Bone Marrow Transplant; 1993 Mar; 11(3):209-14. PubMed ID: 8385522
    [Abstract] [Full Text] [Related]

  • 11. Cytomegalovirus infection after allogeneic transplantation: comparison of cord blood with peripheral blood and marrow graft sources.
    Walker CM, van Burik JA, De For TE, Weisdorf DJ.
    Biol Blood Marrow Transplant; 2007 Sep; 13(9):1106-15. PubMed ID: 17697973
    [Abstract] [Full Text] [Related]

  • 12. Risk factors for cytomegalovirus, hepatitis B and C virus reactivation after bone marrow transplantation.
    Zekri AR, Mohamed WS, Samra MA, Sherif GM, El-Shehaby AM, El-Sayed MH.
    Transpl Immunol; 2004 Dec; 13(4):305-11. PubMed ID: 15589744
    [Abstract] [Full Text] [Related]

  • 13. Prevention and treatment of cytomegalovirus infection and disease after bone marrow transplantation in the 1990s.
    Winston DJ, Gale RP.
    Bone Marrow Transplant; 1991 Jul; 8(1):7-11. PubMed ID: 1655140
    [Abstract] [Full Text] [Related]

  • 14. Reduced risk of persisting cytomegalovirus pp65 antigenemia and cytomegalovirus interstitial pneumonia following allogeneic PBSCT.
    Trenschel R, Ross S, Hüsing J, Ottinger H, Elmaagacli A, Roggendorf M, Schaefer UW, Runde V.
    Bone Marrow Transplant; 2000 Mar; 25(6):665-72. PubMed ID: 10734302
    [Abstract] [Full Text] [Related]

  • 15. Comparison of cytomegalovirus antigenemia and shell vial culture in allogeneic marrow transplantation recipients receiving ganciclovir prophylaxis.
    Nicholson VA, Whimbey E, Champlin R, Abi-Said D, Przepiorka D, Tarrand J, Chan K, Bodey GP, Goodrich JM.
    Bone Marrow Transplant; 1997 Jan; 19(1):37-41. PubMed ID: 9012929
    [Abstract] [Full Text] [Related]

  • 16. Cytomegalovirus infection after bone marrow transplantation in children.
    Castagnola E, Cappelli B, Erba D, Rabagliati A, Lanino E, Dini G.
    Hum Immunol; 2004 May; 65(5):416-22. PubMed ID: 15172440
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Randomized clinical trial of ganciclovir vs acyclovir for prevention of cytomegalovirus antigenemia after allogeneic transplantation.
    Burns LJ, Miller W, Kandaswamy C, DeFor TE, MacMillan ML, Van Burik JA, Weisdorf DJ.
    Bone Marrow Transplant; 2002 Dec; 30(12):945-51. PubMed ID: 12476289
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. CMV infections following allogeneic BMT: risk factors, early treatment and correlation with transplant related mortality.
    Bacigalupo A, Tedone E, Sanna MA, Moro F, Van Lint MT, Grazi G, Balestreri M, Frassoni F, Occhini D, Gualandi F.
    Haematologica; 1992 Dec; 77(6):507-13. PubMed ID: 1337746
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.